Braunwald's Heart Disease - Elsevier eBook on VitalSource, 12th Edition

by Peter Libby, MD, PhD, Robert O. Bonow, MD, MS, Douglas L. Mann, MD, Gordon F. Tomaselli, MD, Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Scott D. Solomon, MD and Eugene Braunwald, MD, MD(Hon), ScD(Hon), FRCP

Elsevier eBook on VitalSource

ISBN: 9780323824736

Publication Date: 11-15-2021

Page Count: 2032

Imprint: Elsevier

List Price: $250.99

Was $250.99

Now $220.87

Or $0.00 with a valid access code

**Selected for Doody’s Core Titles® 2025 with "Essential Purchase" designation in Cardiology**

Current, comprehensive, and evidence-based Braunwald’s Heart Disease remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an unparalleled multimedia reference for every aspect of this complex and fast-changing area.

Key Features
- Offers balanced, dependable content on rapidly changing clinical science, clinical and translational research, and evidence-based medicine
- Includes 76 new contributing authors and 14 new chapters that cover Artificial intelligence in Cardiovascular Medicine; Wearables; Influenza, Pandemics, COVID-19, and Cardiovascular Disease; Tobacco and Nicotine Products in Cardiovascular Disease; Cardiac Amyloidosis; Impact of the Environment on Cardiovascular Health, and more
- Features a new introductory chapter Cardiovascular Disease: Past, Present, and Future by Eugene Braunwald, MD, offering his unique, visionary approach to the field of cardiology. Dr. Braunwald also curates the extensive, bimonthly online updates that include "Hot Off the Press" (with links to Practice Update) and "Late-Breaking Clinical Trials"
- Provides cutting-edge coverage of key topics such as proteomics and metabolomics, TAVR, diabetocardiology, and cardio-oncology
- Contains 1,850 high-quality illustrations, radiographic images, algorithms, and charts, and provides access to 215 videos called out with icons in the print version
- Highlights the latest AHA, ACC, and ESC guidelines to clearly summarize diagnostic criteria and clinical implications
- Provides tightly edited, focused content for quick, dependable reference. Flexible format options include either one or two volumes in print, as well as a searchable eBook with ongoing updates
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices
Contents

Part I Foundations of Cardiovascular Medicine
1. Cardiovascular Disease: Past, Present, and Future
2. Global Burden of Cardiovascular Disease
3. Impact of the Environment on Cardiovascular Health
4. Clinical Trials in Cardiovascular Medicine
5. Clinical Decision-Making in Cardiology
6. Impact of Health Care Policy on Quality, Outcomes, and Equity in Cardiovascular Disease

Part II Individualizing Approaches to Cardiovascular Disease
7. Applications of Genetics to Cardiovascular Medicine
8. Proteomics and Metabolomics in Cardiovascular Medicine
9. Principles of Drug Therapeutics, Pharmacogenomics, and Biologics
10. Biomarkers and Use in Precision Medicine
11. Artificial Intelligence in Cardiovascular Medicine
12. Wearable Devices in Cardiovascular Medicine

Part III Evaluation of The Patient
13. History and Physical Examination: An Evidence-Based Approach
14. Electrocardiography
15. Exercise Physiology and Exercise Electrocardiographic Testing
16. Echocardiography
17. Chest Radiography in Cardiovascular Disease
18. Nuclear Cardiology
19. Cardiovascular Magnetic Resonance Imaging
20. Cardiac Computed Tomography
21. Coronary Angiography and Intravascular Imaging
22. Invasive Hemodynamic Diagnosis of Cardiac Disease
23. Anesthesia and Noncardiac Surgery in Patients with Heart Disease

Part IV Preventive Cardiology
24. The Vascular Biology of Atherosclerosis
25. Primary Prevention of Cardiovascular Disease
26. Systemic Hypertension: Mechanisms, Diagnosis, and Treatment
27. Lipoprotein Disorders and Cardiovascular Disease
28. Cardiovascular Disease Risk of Nicotine and Tobacco Products
29. Nutrition and Cardiovascular and Metabolic Diseases
30. Obesity: Medical and Surgical Management
31. Diabetes and the Cardiovascular System
32. Exercise and Sports Cardiology
33. Comprehensive Cardiac Rehabilitation
34. Integrative Approaches to the Management of Patients with Heart Disease

Part V Atherosclerotic Cardiovascular Disease
35. Approach to the Patient with Chest Pain
36. Coronary Blood Flow and Myocardial Ischemia
37. ST-Elevation Myocardial Infarction: Pathophysiology and Clinical Evolution
38. ST-Elevation Myocardial Infarction: Management
39. Non–ST Elevation Acute Coronary Syndromes
40. Stable Ischemic Heart Disease
41. Percutaneous Coronary Intervention
42. Diseases of the Aorta
43. Peripheral Artery Diseases
44. Treatment of Noncoronary Obstructive Vascular Disease
45. Prevention and Management of Ischemic Stroke

Part VI Heart Failure
46. Mechanisms of Cardiac Contraction and Relaxation
47. Pathophysiology of Heart Failure
48. Approach to the Patient with Heart Failure
49. Diagnosis and Management of Acute Heart Failure
50. Management of Heart Failure Patients with Reduced Ejection Fraction
51. Heart Failure with Preserved and Mildly Reduced Ejection Fraction
52. The Dilated, Restrictive, and Infiltrative Cardiomyopathies
53. Cardiac Amyloidosis
54. Hypertrophic Cardiomyopathy
55. Myocarditis
56. Cardio-Oncology: Managing Cardiotoxic Effects of Cancer Therapies
57. Cardio-Oncology: Approach to the Patient
58. Devices for Monitoring and Managing Heart Failure
59. Mechanical Circulatory Support
60. Cardiac Transplantation

Part VII Arrhythmias, Sudden Death, and Syncope
61. Approach to the Patient with Cardiac Arrhythmias
62. Mechanisms of Cardiac Arrhythmias
63. Genetics of Cardiac Arrhythmias
64. Therapy for Cardiac Arrhythmias
65. Supraventricular Tachycardias
66. Atrial Fibrillation: Clinical Features, Mechanisms, and Management
67. Ventricular Arrhythmias
68. Bradyarrhythmias and Atrioventricular Block
69. Pacemakers and Implantable Cardioverter-Defibrillators
70. Cardiac Arrest and Sudden Cardiac Death
71. Hypotension and Syncope

Part VIII Diseases of the Heart Valves
72. Aortic Valve Stenosis
73. Aortic Regurgitation
74. Transcatheter Aortic Valve Replacement
75. Mitral Stenosis
76. Mitral Regurgitation
77. Tricuspid, Pulmonic, and Multivalvular Disease
78. Transcatheter Therapies for Mitral and Tricuspid Valvular Heart Disease
79. Prosthetic Heart Valves
80. Infectious Endocarditis and Infections of Indwelling Devices
81. Rheumatic Fever

Part IX Diseases of the Myocardium, Pericardium, and Pulmonary Vasculature Bed
82. Congenital Heart Disease in the Adolescent and Adult
83. Catheter-Based Treatment of Congenital Heart Disease in Adults
84. Cardiomyopathies Induced by Drugs or Toxins
85. Cardiovascular Abnormalities in HIV-Infected Individuals
86. Pericardial Diseases
87. Pulmonary Embolism and Deep Vein Thrombosis
88. Pulmonary Hypertension
89. Sleep-Disordered Breathing and Cardiac Disease

Part X Cardiovascular Disease in Select Populations
90. Cardiovascular Disease in Older Adults
91. Cardiovascular Disease in Women
92. Pregnancy and Heart Disease
93. Heart Disease in Racially and Ethnically Diverse Populations

Part XI Cardiovascular Disease and Disorders of Other Organs
94. Endemic and Pandemic Viral Illnesses and Cardiovascular Disease: Influenza and COVID-19
95. Hemostasis, Thrombosis, Fibrinolysis, and Cardiovascular Disease
96. Endocrine Disorders and Cardiovascular Disease
97. Rheumatic Diseases and the Cardiovascular System
98. Tumors Affecting the Cardiovascular System
99. Psychiatric and Psychosocial Aspects of Cardiovascular Disease
100. Neuromuscular Disorders and Cardiovascular Disease
101. Interface Between Renal Disease and Cardiovascular Illness
102. Cardiovascular Manifestations of Autonomic Disorders
Authors

Peter Libby, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School, USA, Robert O. Bonow, MD, MS, Northwestern University, Feinberg School of Medicine, USA, Douglas L. Mann, MD, Washington University, School of Medicine, USA, Gordon F. Tomaselli, MD, Executive Vice President; Chief Academic Officer; Dean Montefiore Medicine; Professor, Department of Medicine Einstein College of Medicine, Yeshiva University, Bronx, New York, USA, Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Director of Mount Sinai Fuster Heart Hospital, Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Scott D. Solomon, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA and Eugene Braunwald, MD, MD(Hon), ScD(Hon), FRCP, Distinguished Hersey Professor of Medicine, Harvard Medical School, Founding Chairman, TIMI Study Group, Brigham and Women ’s Hospital, Boston, Massachusetts, USA
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - No information about nonvisual reading is available
- Conformance
  - No information is available
- Navigation
  - Table of contents to all chapters of the text via links
  - Page list to go to pages from the print source version
- Rich Content
  - No information is available
- Hazards
  - No information is available
- Product Content
  - No information is available
- Legal Considerations
  - No information is available
- Additional Accessibility Information
  - Page breaks included from the original print source
  - For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.